5-146878727-AGCTGCTGCTGCTGCTGCTGCTGCT-AGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCT

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BA1

The ENST00000530902.5(PPP2R2B):​n.153_167dupAGCAGCAGCAGCAGC variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.097 ( 713 hom., cov: 0)
Exomes 𝑓: 0.10 ( 6937 hom. )
Failed GnomAD Quality Control

Consequence

PPP2R2B
ENST00000530902.5 non_coding_transcript_exon

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 3.19

Publications

4 publications found
Variant links:
Genes affected
PPP2R2B (HGNC:9305): (protein phosphatase 2 regulatory subunit Bbeta) The product of this gene belongs to the phosphatase 2 regulatory subunit B family. Protein phosphatase 2 is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The B regulatory subunit might modulate substrate selectivity and catalytic activity. This gene encodes a beta isoform of the regulatory subunit B55 subfamily. Defects in this gene cause autosomal dominant spinocerebellar ataxia 12 (SCA12), a disease caused by degeneration of the cerebellum, sometimes involving the brainstem and spinal cord, and in resulting in poor coordination of speech and body movements. Multiple alternatively spliced variants, which encode different isoforms, have been identified for this gene. The 5' UTR of some of these variants includes a CAG trinucleotide repeat sequence (7-28 copies) that can be expanded to 55-78 copies in cases of SCA12. [provided by RefSeq, Jul 2016]
PPP2R2B Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 12
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 5-146878727-A-AGCTGCTGCTGCTGCT is Benign according to our data. Variant chr5-146878727-A-AGCTGCTGCTGCTGCT is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 218860.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.117 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PPP2R2BNM_181675.4 linkc.-276_-262dupAGCAGCAGCAGCAGC 5_prime_UTR_variant Exon 1 of 10 ENST00000394411.9 NP_858061.3 Q00005-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PPP2R2BENST00000394411.9 linkc.-276_-262dupAGCAGCAGCAGCAGC 5_prime_UTR_variant Exon 1 of 10 2 NM_181675.4 ENSP00000377933.3 Q00005-1

Frequencies

GnomAD3 genomes
AF:
0.0968
AC:
14559
AN:
150420
Hom.:
709
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0771
Gnomad AMI
AF:
0.0833
Gnomad AMR
AF:
0.0788
Gnomad ASJ
AF:
0.116
Gnomad EAS
AF:
0.0657
Gnomad SAS
AF:
0.125
Gnomad FIN
AF:
0.0518
Gnomad MID
AF:
0.103
Gnomad NFE
AF:
0.119
Gnomad OTH
AF:
0.0988
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.101
AC:
109718
AN:
1087864
Hom.:
6937
Cov.:
27
AF XY:
0.104
AC XY:
55423
AN XY:
534104
show subpopulations
African (AFR)
AF:
0.0771
AC:
1763
AN:
22856
American (AMR)
AF:
0.0840
AC:
2229
AN:
26540
Ashkenazi Jewish (ASJ)
AF:
0.133
AC:
1979
AN:
14898
East Asian (EAS)
AF:
0.0832
AC:
1848
AN:
22206
South Asian (SAS)
AF:
0.115
AC:
8174
AN:
71258
European-Finnish (FIN)
AF:
0.102
AC:
1574
AN:
15420
Middle Eastern (MID)
AF:
0.111
AC:
303
AN:
2738
European-Non Finnish (NFE)
AF:
0.100
AC:
87238
AN:
870982
Other (OTH)
AF:
0.113
AC:
4610
AN:
40966
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.448
Heterozygous variant carriers
0
3572
7144
10717
14289
17861
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3112
6224
9336
12448
15560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0968
AC:
14569
AN:
150536
Hom.:
713
Cov.:
0
AF XY:
0.0940
AC XY:
6901
AN XY:
73432
show subpopulations
African (AFR)
AF:
0.0773
AC:
3168
AN:
40982
American (AMR)
AF:
0.0789
AC:
1196
AN:
15164
Ashkenazi Jewish (ASJ)
AF:
0.116
AC:
403
AN:
3460
East Asian (EAS)
AF:
0.0656
AC:
322
AN:
4906
South Asian (SAS)
AF:
0.124
AC:
583
AN:
4696
European-Finnish (FIN)
AF:
0.0518
AC:
541
AN:
10440
Middle Eastern (MID)
AF:
0.107
AC:
31
AN:
290
European-Non Finnish (NFE)
AF:
0.119
AC:
8048
AN:
67612
Other (OTH)
AF:
0.0968
AC:
202
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
640
1279
1919
2558
3198
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0467
Hom.:
47

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 17, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

PPP2R2B-related disorder Benign:1
Feb 20, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.2
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10591869; hg19: chr5-146258290; API